New tools for the generation of E1- and/or E3-substituted adenoviral vectors
- 1 January 2000
- journal article
- research article
- Published by Springer Nature in Gene Therapy
- Vol. 7 (1) , 80-87
- https://doi.org/10.1038/sj.gt.3301047
Abstract
We have designed new vectors for the construction of recombinant adenoviruses containing expression cassettes in the E1 and/or E3 regions. Using a versatile set of restriction enzymes, the cassettes are cloned into small bacterial vectors and subsequently introduced into large plasmids containing the adenoviral sequences. Two positive selection markers facilitate the recovery of a cosmid containing a copy of the sequence of the recombinant adenovirus. The resulting cosmid is transfected into 293 or 911 cells in order to rescue the virus. Importantly, the method does not require any recombination event, either in E. coli or in mammalian cells. The entire procedure can generate viral plaques in 12 days.Keywords
This publication has 22 references indexed in Scilit:
- Efficient Construction of a Recombinant Adenovirus Vector by an ImprovedIn VitroLigation MethodHuman Gene Therapy, 1998
- High throughput method for creating and screening recombinant adenovirusesGene Therapy, 1998
- Viral vectors for gene therapyTrends in Biotechnology, 1998
- Use of the Cosmid Adenoviral Vector Cloning System for theIn VitroConstruction of Recombinant Adenoviral VectorsHuman Gene Therapy, 1997
- Recombinational construction in Escherichia coli of infectious adenoviral genomesProceedings of the National Academy of Sciences, 1997
- A new adenoviral vector: Replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and beta-galactosidase.Proceedings of the National Academy of Sciences, 1996
- Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome.Proceedings of the National Academy of Sciences, 1996
- Efficient manipulation of the human adenovirus genome as an infectious yeast artificial chromosome clone.Proceedings of the National Academy of Sciences, 1994
- Gene therapy: adenovirus vectorsCurrent Opinion in Genetics & Development, 1993
- A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5Virology, 1988